Advisers to the Food and Drug Administration on Friday must confront a range of bewildering scientific questions before deciding whether to authorize coronavirus vaccine booster shots — and if so, for whom.Three important pieces of research landed just this week. On Monday, in the journal The Lancet, an international team of scientists analyzed dozens of…
